NASDAQ:OFIX - Orthofix Medical Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $45.67
  • Forecasted Upside: 19.95 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$38.07
▼ -0.07 (-0.18%)
1 month | 3 months | 12 months
Get New Orthofix Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OFIX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OFIX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$45.67
▲ +19.95% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Orthofix Medical in the last 3 months. The average price target is $45.67, with a high forecast of $56.00 and a low forecast of $39.00. The average price target represents a 19.95% upside from the last price of $38.07.
Hold
The current consensus among 3 polled investment analysts is to hold stock in Orthofix Medical. This rating has held steady since September 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/8/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/5/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/29/2020

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/20/2020Stifel NicolausInitiated CoverageHold$39.00Medium
i
2/25/2020SidotiLower Price TargetBuy$70.00 ➝ $56.00High
i
2/25/2020Cantor FitzgeraldLower Price TargetNeutral$48.00 ➝ $42.00High
i
Rating by C. Bijou at Cantor Fitzgerald
10/29/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$71.00 ➝ $48.00Low
i
Rating by C. Bijou at Cantor Fitzgerald
2/26/2019BTIG ResearchReiterated RatingBuy ➝ NeutralHigh
i
1/18/2019Cantor FitzgeraldSet Price TargetBuy$60.00Low
i
Rating by Craig Bijou at Cantor Fitzgerald
1/8/2019Cantor FitzgeraldSet Price TargetBuy$66.00Low
i
Rating by Craig Bijou at Cantor Fitzgerald
8/7/2018Cantor FitzgeraldBoost Price TargetOverweight$66.00High
i
Rating by C. Bijou at Cantor Fitzgerald
5/31/2018Cantor FitzgeraldInitiated CoverageOverweight$62.00Medium
i
Rating by C. Bijou at Cantor Fitzgerald
3/5/2018SunTrust BanksBoost Price TargetBuy$67.00High
i
2/28/2018GabelliReiterated RatingBuyLow
i
Rating by J. Tsai at Gabelli
10/30/2017BTIG ResearchSet Price TargetBuy$56.00N/A
i
Rating by Ryan Zimmerman at BTIG Research
8/10/2017Jefferies Financial GroupReiterated RatingBuy$50.00 ➝ $55.00Low
i
6/21/2017BTIG ResearchInitiated CoverageBuy$52.00High
i
6/14/2017Langenberg & CompanyReiterated RatingBuy$53.25Low
i
6/14/2017LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$53.25Low
i
5/23/2017SunTrust BanksInitiated CoverageBuy ➝ Buy$49.00Medium
i
(Data available from 11/29/2015 forward)
Orthofix Medical logo
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion as well as used as a therapeutic treatment for non-spinal appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Read More

Today's Range

Now: $38.07
$37.65
$38.31

50 Day Range

MA: $34.87
$31.26
$38.67

52 Week Range

Now: $38.07
$22.11
$47.91

Volume

26,280 shs

Average Volume

134,679 shs

Market Capitalization

$736.05 million

P/E Ratio

31.73

Dividend Yield

N/A

Beta

1.01